First CaPP3 Recruit
Nick James, our first CaPP3 participant, was recruited in
Newcastle by Professor Sir John Burn on 1st October 2014.
CaPP3 Study Day
A meeting to facilitate the clinical study approval process for
the CaPP3 Study held on Wednesday 26th February 2014 at Centre
CaPP3 is go!
Now that we have the result of the CAPP2 study which shows that
regular aspirin significantly reduces cancer risk in Lynch
syndrome, we now need to try and work out the best dose.